Vitamin D was also tried in a dual combination with GAD65 Alum in a phase 2b study in 109 recent-onset T1D patients aged 12–24 years old (treatment: 57 patients, placebo: 52 patients; Ludvigsson et al, 2021b). The gene discussed is GAD2; the disease is type 1 diabetes mellitus.